Atlas Trials

The Role of Glucagon in the Effects of Dipeptidyl Peptidase-4 Inhibitors and Sodium-glucose Co-transporter-2 Inhibitors

Clinical trial NCT02792400 · COMPLETED

Trial details

NCT number
NCT02792400
Sponsor
University Hospital, Gentofte, Copenhagen
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Type 2 Diabetes
Start date
2016-05-01
Primary completion
2016-08-01
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.